JB Consulting MDP Limited: Shaping the Future of Precision Medicine Through Integrated Therapeutic–Diagnostic Strategy

Redefining Excellence in Precision‑Medicine Consultancy

JB Consulting MDP Limited stands at the forefront of the evolving landscape of pharmaceutical, diagnostic, and medical device innovation. As winner of the M&A Today – Global Awards – 2026 for Leading Consultant in Pathology & Pharmaceutical Medicine and Best Diagnostic Pathology Services, the firm continues to define new standards in therapeutic–diagnostic integration.

Championing the New Standard in Medicine

Modern healthcare demands more than traditional drug development. Precision medicine relies on the alignment of targeted therapies with clinically meaningful biomarkers and validated diagnostic tools. JB Consulting MDP Limited specialises in guiding organisations through this interconnected pathway, ensuring that therapeutics and diagnostics evolve together for maximum clinical impact.

The consultancy supports clients across the full continuum of precision‑medicine development, including:

• Identifying and validating biomarkers that support patient stratification
• Designing diagnostic strategies linked to therapeutic mechanisms
• Navigating co‑development pathways for companion diagnostics
• Ensuring commercial readiness for therapy‑diagnostic launches

By bridging two historically separate sectors—pharmaceutical medicine and diagnostic science—the firm empowers innovators to deliver therapies with unprecedented accuracy and patient relevance.

Driving Tomorrow’s Targeted Therapies

With oncology, immunology, rare diseases, and pharmacogenomics shaping today’s therapeutic evolution, the need for robust companion diagnostics has never been greater. JB Consulting MDP Limited works with clients to advance innovation from concept to clinic, supporting biomarker discovery, regulatory strategy, commercial insight, and clinical implementation.

Their integrated approach strengthens each phase of development, ultimately improving patient outcomes through data‑driven precision and scientifically validated diagnostic support.

Why Organisations Trust JB Consulting MDP Limited

The firm’s unique value lies in its combination of scientific, clinical, and commercial expertise. Clients benefit from a rare blend of experience that spans:

• Diagnostic expertise including chemical pathology, molecular diagnostics, and assay validation
• Pharmaceutical development insight covering regulatory science, clinical strategy, and market alignment
• Hands‑on implementation experience across health systems and industry environments
• A precision‑medicine mindset that ensures scientific innovation translates into real‑world application

This holistic perspective allows the organisation to navigate complex regulatory, clinical, and commercial landscapes with clarity and confidence.

A Proven Foundation of Scientific Excellence

Beyond advisory services, JB Consulting MDP Limited contributes directly to scientific research through international publications focused on diagnostics, assay performance, and point‑of‑care technologies. Their involvement underscores a commitment to rigorous scientific validation and evidence‑based consultancy.

Committed to Advancing Global Healthcare

With a footprint that includes offices within internationally recognised innovation centres, JB Consulting MDP Limited continues to expand its influence in shaping how therapeutics and diagnostics are developed, evaluated, and integrated into clinical care. The firm’s leadership in precision medicine reflects both deep scientific knowledge and an unwavering commitment to improving patient outcomes worldwide.

Contact Information

JB Consulting MDP Limited
Cherwell Innovation Centre, 77 Heyford Park, Upper Heyford, Oxfordshire, OX25 5HD, United Kingdom
Email: john.bolodeoku@jbconsultingmdp.com